Skip to main content
Molecular and Clinical Oncology logoLink to Molecular and Clinical Oncology
. 2018 Apr 13;8(6):779–784. doi: 10.3892/mco.2018.1607

Preoperative evaluation of skeletal muscle mass in the risk assessment for the short-term outcome of elderly colorectal cancer patients undergoing colectomy

Hiroshi Tamagawa 1,2,, Toru Aoyama 1, Kenta Iguchi 1,2, Hirohito Fujikawa 1,2, Sho Sawazaki 1,2, Tsutomu Sato 1, Hiroyuki Musiake 1, Takashi Oshima 1, Norio Yukawa 1, Yasushi Rino 1, Munetaka Masuda 1
PMCID: PMC5958782  PMID: 29805792

Abstract

The prevalence of colorectal cancer in the elderly population is increasing; therefore, surgical interventions with a risk of potential complications are more frequently performed. The aim of the present study was to elucidate whether sarcopenia has a clinical impact on short-term outcomes, such as morbidity and hospital stay after surgery, in elderly patients with colorectal cancer. A total of 82 elderly patients undergoing colectomy for colorectal cancer between January 2011 and December 2015 in our institute were included in the study, and skeletal muscle mass was measured as total psoas area at the level of the third lumbar vertebra (L3) using enhanced computed tomography scans. The patients were divided into two subgroups, namely those with and those without sarcopenia, based on median skeletal muscle mass in men and women, and the association with complications was analyzed. A total of 40 patients (48.8%) were diagnosed with sarcopenia. The patients with sarcopenia exhibited a significantly higher incidence of total complications (55 vs. 31.0%, P=0.028) and longer hospital stay (25.9±21.2 vs. 18.2±8.5 days, P=0.039). The multivariate logistic analysis revealed that sarcopenia was an independent risk factor for postoperative surgical complications. The short-term outcomes, such as postoperative surgical complications and hospital stay, were affected by preoperative sarcopenia in elderly colorectal cancer patients. To improve the short-term outcomes of such patients, it is necessary to carefully plan the surgical procedure, perioperative care and the surgical strategy using preoperative sarcopenia assessment.

Keywords: sarcopenia, colorectal cancer, complications

Introduction

Colorectal cancer is the third most commonly diagnosed cancer in men and the second in women, with an estimated 1.4 million new cases and 693,900 deaths occurring in 2012 (1,2). Complete resection is crucial for the cure of colorectal cancer. However, the morbidity and mortality of radical colectomy are 20–30 and 1–2%, respectively (37).

The number of elderly patients with colorectal cancer is rapidly growing worldwide. With individuals aged ≥80 years representing the fastest growing subset of the population, the management of complex surgical issues is becoming increasingly more challenging (8). Elderly patients more often have co-morbidities and age-related physiological problems compared with non-elderly patients. Elderly patients are likely to exhibit a reduction in skeletal muscle mass and function with aging (9). Skeletal muscle is crucial to physical function, health and quality of life, while muscle mass and strength are clearly compromised in elderly patients (10).

It was recently demonstrated that preoperative sarcopenia is a risk factor for surgical complications (11,12). In addition, a number of previous studies have demonstrated that the development of postoperative complications increases the risk of disease recurrence in various types of malignancies (1316). Therefore, it is important to predict the occurrence of complications prior to surgery and to determine the most appropriate perioperative care.

The aim of the present study was to elucidate whether sarcopenia has a clinical impact on short-term outcomes, such as morbidity and hospital stay after surgery, in elderly patients with colorectal cancer.

Patients and methods

Patients

A total of 82 consecutive patients were selected from the database of the Department of Surgery of Kamishirane Hospital (Yokohama, Japan) according to the following criteria: i) Histologically-proven colorectal adenocarcinoma, ii) patients who underwent curative colectomy for colorectal cancer as a primary treatment between January 2011 and October 2016, iii) patients who did not experience weight loss prior to surgery and iv) patients who had undergone abdominal computed tomography (CT) imaging within 1 month prior to surgery.

Assessment of skeletal muscle mass

To assess skeletal muscle mass related to sarcopenia, which is defined as a decrease in muscle mass due to aging and/or other causes, the skeletal muscle area at the level of the third lumbar vertebra (L3) in a preoperative CT horizontal section [psoas muscle index (PMI), calculated as psoas muscle cross-sectional area (cm2)/height (m2)] was used to calculate the median of each man and woman as a cut-off value. Regarding the actual measurement of the skeletal muscle area, the outline of the large psoas muscle was traced as the region of interest in the CT image and the total area was calculated.

Surgical procedure

The type of the surgical approach was determined by each surgeon. In principle, laparoscopic-assisted surgery was performed by a 5-port method under general and epidural anesthesia (17). Functional end-to-end anastomosis was performed for right-sided colectomy, and the double-stapling technique was performed for left-sided colectomy and anterior resection of the rectum. The number and position of intra-abdominal drainage tubes were determined by each surgeon. Pathological staging was performed according to the Union for International Cancer Control classification (18). The appropriate length of resection and the levels of lymph node dissection were determined by the 2010 Japanese Society for Cancer of the Colon and Rectum Guidelines (19,20).

Perioperative care

In principle, the patients received the same perioperative care. In brief, the patients were allowed to eat until midnight on the day prior to surgery and were required to drink the contents of two 500-ml bottles containing oral rehydration solution until 3 h prior to surgery. The nasogastric tube was removed on postoperative day (POD) 1. Oral intake was initiated on POD 2, beginning with water and an oral nutritional supplement. The patients began to eat solid food on POD 3, starting with rice gruel and soft food on POD 3 and advancing stepwise to regular food intake on POD 7. The patients were discharged when they had achieved adequate pain relief and soft food intake, had returned to their preoperative mobility level and had normal laboratory results.

Evaluation of operative morbidity and mortality

Surgical and non-surgical complications were assessed prospectively and were classified according to the Clavien-Dindo classification (21). Operative mortality was defined as postoperative death from any cause within 30 days after surgery or during the same hospital stay.

Evaluations and statistical analyses

Univariate and multivariate logistic regression analyses were performed to identify the risk factors for morbidity. Comparisons between the two groups were analyzed by the Chi-squared test. Linear regression models were fitted to the multivariate analysis. To select a model, backward elimination was used. All statistical tests were two-sided, and significance was set at P<0.05. The SPSS software package (v11.0 J Win; SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. This study was approved by the Institutional Review Board of the Kamishirane Hospital.

Results

Patients

A total of 82 patients were selected for this study. The clinicopathological characteristics of the patients are summarized in Table I. The median age of the study population was 85 years, 38 patients were male and 44 were female. Of the 82 patients, 31 received right-sided colectomy, 39 received left-sided colectomy, and 11 underwent rectal resection. The median duration of the surgery was 125 min (range, 62–287 min) and the median blood loss was 110 ml (range, 50–1,250 ml).

Table I.

Patient demographic and clinicopathological characteristics.

Factors All (n=82) Sarcopenia (n=40) No sarcopenia (n=42) P-value
Sex, n (%) 0.837
  Male 38 (46.3) 19 (47.5) 19 (45.2)
  Female 44 (53.7) 21 (52.5) 23 (54.8)
Age (mean ± SD), years 86.1±4.9 86.4±4.8 85.6±5.0 0.444
BMI (mean ± SD), kg/m2 20.7±3.9 21.7±4.2 19.8±3.1 0.023a
ASA grade, n (%) 0.621
  I, II 33 (40.2) 15 (37.5) 18 (42.9)
  III, IV 49 (58.8) 25 (62.5) 24 (57.1)
Comorbidities, n (%)
  Hypertension 42 21 (52.5) 21 (50.0) 0.821
  Diabetes mellitus 16 7 (17.5) 9 (21.4) 0.654
  Cerebrovascular disease 13 8 (20.0) 5 (11.9) 0.316
  COPD 6 4 (10.0) 2 (4.8) 0.363
Tumor location, n (%) 0.665
  Colon 72 34 (87.2) 38 (90.2)
  Rectum 9 5 (12.8) 4 (9.8)
Pathological T factor, n (%) 0.097
  T1, T2 13 4 (10.0) 9 (23.8)
  T3, T4 68 36 (90.0) 32 (76.2)
Pathological N factor, n (%) 0.852
  Negative 47 23 (57.5) 24 (59.5)
  Positive 34 17 (42.5) 17 (40.5)
Pathological stage, n (%) 0.738
  I/II 41 21 (52.5) 20 (48.8)
  III/IV 40 19 (47.5) 21 (51.2)
a

Statistically significant difference. BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; SD, standard deviation.

Cut-off values for L3 skeletal muscle mass index (SMI)

The sex-specific cut-off values for L3 SMI associated with complications were 11.9 cm2/m2 for men and 9.6 cm2/m2 for women, obtained by means of optimum stratification. Using these cut-off values, 48.8% of the patients were found to be sarcopenic. Clinical associations in patients with or without sarcopenia are shown in Tables I and II. Patients with sarcopenia exhibited a higher BMI compared with those without sarcopenia (P=0.023).

Table II.

Patient preoperative laboratory data.

Factors All (n=82) Sarcopenia (n=40) No sarcopenia (n=42) P-value
Hemoglobin (g/dl) 11.1±2.0 10.8±1.9 11.3±2.0 0.110
Total protein (g/dl) 6.2±0.7 6.2±0.9 6.3±0.6 0.602
Albumin (g/dl) 3.3±0.6 3.3±0.5 3.2±0.6 0.543
C-reactive protein (mg/dl) 0.32±0.24 0.41±0.15 0.23±0.20 0.090

Surgical morbidity and mortality

Postoperative complications were observed in 35 of the 189 patients (42.7%). Surgical-related mortality was reported in 3 cases in the present study. The details of the complications are presented in Table III. Ileus and surgical site infection were the most frequently diagnosed complications, followed by pneumonia and anastomotic leakage.

Table III.

Postoperative surgical complications according to the Clavien-Dindo classification.

Grade Complications No.
II TIA 1
SSI 9
Ileus 2
Pneumonia 3
Colitis 2
Urinary tract infection 3
Renal failure 1
IIIa Pleural effusion 1
Intraperitoneal abscess 1
Ileus 5
IIIb Anastomotic leakage 2
Gallbladder perforation 1
Ileus 1
IVa Anastomotic leakage 1
V Pneumonia 2
Heart failure 1

TIA, transient ischemic attack; SSI, surgical site infection.

Risk factors for surgical morbidity

The risk factors for surgical morbidity were analyzed by univariate and multivariate analyses using the preoperative and perioperative factors. The results are summarized in Table IV. Among the various factors examined, sarcopenia (P=0.027) and intraoperative bleeding (P=0.010) were identified as statistically significant independent risk factors for overall morbidity.

Table IV.

Univariate and multivariate logistic regression analysis for postoperative surgical complications.

Univariate analysis Multivariate analysis


Factors OR (95% CI) P-value OR (95% CI) P-value
Sarcopenia
  No 1.000 1.000
  Yes 2.726 (1.105–6.728) 0.030 3.508 (1.154–10.653) 0.027
Age, years
  <85 1.000
  ≥85 0.741 (0.308–1.783) 0.503
BMI, kg/m2
  <20 1.000
  ≥20 1.837 (0.745–4.528) 0.187
ASA grade
  I, II 1.000
  III, IV 2.396 (0.945–6.072) 0.066
Cerebrovascular disorders
  No 1.000 1.000
  Yes 3.721 (1.040–13.310) 0.043a 3.612 (0.741–17.607) 0.112
Diabetes mellitus
  No 1.000
  Yes 0.766 (0.249–2.353) 0.641
COPD
  No 1.000
  Yes 2.903 (0.501–16.804) 0.235
Operative time, min
  <120 1.000
  ≥120 2.140 (0.825–5.552) 0.118
Intraoperative bleeding, ml
  <100 1.000 1.000
  ≥100 4.556 (1.713–12.118) 0.002a 4.222 (1.416–12.592) 0.010a
a

Statistically significant difference. BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; OR, odds ratio; CI, confidence interval.

Discussion

The aim of the present study was to elucidate whether preoperative sarcopenia has a clinical impact on short-term outcomes, such as morbidity and hospital stay after surgery, in elderly patients with colorectal cancer. The major finding of the present study was that both short-term outcomes were affected by preoperative sarcopenia in elderly patients with colorectal cancer. A high degree of sarcopenia was an independent risk factor for postoperative complications and longer hospital stay. To improve the short-term outcomes of sarcopenic elderly patients with colorectal cancer, it is necessary to carefully plan the surgical procedure, perioperative care and surgical strategy.

First, regarding the association between preoperative sarcopenia and postoperative surgical complications, the present study demonstrated that preoperative sarcopenia was an independent risk factor for surgical complications in elderly patients with colorectal cancer. Similar results have also been observed for other malignancies. For example, Margadant et al examined the prognostic value of muscle density as a predictor of postoperative complications in 373 elderly patients undergoing surgery for colorectal cancer (22). The Hounsfield Unit Average Calculation (HUAC or HU/mm2) of the psoas muscles at the level of the L3 was calculated on the scan. High and low muscle density groups were identified based on the lowest sex-specific HUAC quartile. The cut-off point for the lowest sex-specific quartile was ≤22.0 HU/mm2 for men and ≤23.5 HU/mm2 for women. A statistically significant association was observed between muscle density and a Clavien-Dindo score of ≥3 [odds ratio=1.84 (95% confidence interval: 1.11–3.06), P=0.019]. In addition, anastomotic leakage in patients with a primary anastomosis (n=287) occurred more frequently in patients with low muscle density (11.7 vs. 23.3%, P=0.016). It was concluded that low muscle density is associated with major postoperative complications in older patients who undergo surgery for colorectal cancer. Moreover, Boer et al investigated the role of low skeletal muscle mass (sarcopenia) as prognostic factor for postoperative complications and survival in 91 patients with resectable colon cancer (23). In that study, skeletal muscle mass was measured as total psoas area and total abdominal muscle area at three anatomical levels on the preoperative CT scan. The study included 91 patients with a mean age of 71.2±9.7 years. Sarcopenia was found to be an independent risk factor for one or more complications. Taken together, the results of previous studies and the results of the present study indicate that preoperative sarcopenia may have a clinical impact on postoperative surgical complications in elderly patients with colorectal cancer. Further investigation should focus on the exact mechanism underlying the association between preoperative sarcopenia and the development of postoperative complications.

Second, in the present study, the hospital stay was significantly longer in patients with preoperative sarcopenia compared with those without preoperative sarcopenia (P=0.039). Previous studies reported a similar trend. For example, Lieffers et al evaluated whether sarcopenia predicts primary colorectal cancer resection outcomes in stage II–IV patients (n=234) (24). In that study, sarcopenia was assessed using preoperative CT images. Overall, 38.9% of the patients were found to be sarcopenic. The length of hospital stay was longer for sarcopenic patients (15.9±14.2 vs. 12.3±9.8 days, P=0.038), particularly for those aged >65 years (20.2±16.9 vs. 13.1±8.3 days, P=0.008). In addition, Malietzis et al investigated the role of particular body composition profiles as prognostic markers for patients with colorectal cancer undergoing curative resection (25). Lumbar SMI, visceral adipose tissue surface area and mean muscle attenuation were calculated by analysis of CT images in their study, and the presence of myosteatosis was found to be associated with prolonged primary hospital stay (P=0.034). These findings require confirmation by future prospective studies to determine the potential additional use of health services, such as home care, as well as the impact on quality of life and costs associated with sarcopenia.

There were certain differences when comparing the present with previous studies. First, the definition of elderly patients was different. We herein defined elderly patients as those aged ≥80 years, while elderly patients were defined as those aged ≥70 or ≥75 years in previous studies. Second, the definition and severity of the postoperative surgical complications were different. Complications of grade 2–5 according to the Clavien-Dindo classification that occurred during hospitalization and/or within 30 days after surgery were retrospectively determined from the patients' records in the present study, while complications of grade ≥3 according to the Clavien-Dindo classification were taken into consideration in previous studies. Third, the perioperative care, which affects the hospital stay after surgery and the frequency of postoperative complications, was different. The perioperative care was standardized and the same fast-track program was applied to all patients after surgery in the present study, while the perioperative care was not standardized in previous studies.

There were also certain limitations to the present study. First, this was a retrospective single-center study with a small sample size, and our findings may be due to chance alone. Second, the cut-off points for sarcopenia should be determined within each specific patient population and BMI category (obese, overweight, normoweight or underweight). In the present study, sarcopenia was defined based on the results of the previous studies. However, the cut-off value may depend on the patients' backgrounds. Thus, an appropriate cut-off value should be determined in other validation studies in other populations. A significantly larger sample would be required to undertake a cut-off point analysis. Third, there was a selection bias in the elderly patients in this series. Surgeons often avoid performing colectomy in elderly patients, as the procedure itself has a 1% mortality and 20–30% morbidity risk. Thus, the fact that elderly patients in this study received colectomy may itself be a potential source of bias.

In conclusion, the short-term outcomes were adversely affected by preoperative sarcopenia in elderly patients with colorectal cancer. Our results indicated preoperative sarcopenia as an independent risk factor for postoperative complications and hospital stay. To improve the short-term outcomes of elderly sarcopenic patients with colorectal cancer, it is necessary to carefully plan the surgical procedure, perioperative care and surgical strategy.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

HT and TA designed the study, performed the majority of the experiments and wrote the manuscript. HT and TA analyzed the patient's data. KI, HF, SS, TS, HM, TO, NY, YR and MM helped analyze patients' skeletal muscle mass data.

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of the Kamishirane Hospital.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

  • 1.Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, et al. A Randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372:1324–1332. doi: 10.1056/NEJMoa1414882. [DOI] [PubMed] [Google Scholar]
  • 2.Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
  • 3.Hazebroek EJ. Color Study Group: COLOR: A randomized trial comparing laparoscopic and open resection for colon cancer. Surg Endosc. 2002;16:949–953. doi: 10.1007/s00464-001-8165-z. [DOI] [PubMed] [Google Scholar]
  • 4.Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, Visa J. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet. 359:2224–2229. doi: 10.1016/S0140-6736(02)09290-5. [DOI] [PubMed] [Google Scholar]
  • 5.Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM. UK MRC CLASICC Trial Group: Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASSIC Trial GROUP. J Clin Oncol. 2007;25:3061–3068. doi: 10.1200/JCO.2006.09.7758. [DOI] [PubMed] [Google Scholar]
  • 6.Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM. MRC CLASICC trial group: Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): Multicenter, randomised controlled trial. Lancet. 2005;365:1718–1726. doi: 10.1016/S0140-6736(05)66545-2. [DOI] [PubMed] [Google Scholar]
  • 7.Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Survival outcomes of an open-label, non-inferiority, randomized controlled trial. Lancet Oncol. 2014;15:767–774. doi: 10.1016/S1470-2045(14)70205-0. [DOI] [PubMed] [Google Scholar]
  • 8.Simmonds PD, Best L, Geroge S, Williams C. Colorectal cancer collaborative group: Surgery for colorectal cancer in elderly patients: A systematic review. colorectal cancer collaborative group. Lancet. 2000;356:968–974. doi: 10.1016/S0140-6736(00)02713-6. [DOI] [PubMed] [Google Scholar]
  • 9.Russo A, Marana E, Viviani D, Polidori L, Colicci S, Mettimano M, Proietti R, Di Stasio E. Diastolic function: The influence of pneumoperitoneum and Trendelenburg positioning during laparoscopic hysterectomy. Eur J Anaesthseiol. 2009;26:923–927. doi: 10.1097/EJA.0b013e32832cb3c9. [DOI] [PubMed] [Google Scholar]
  • 10.Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P. Nutritional assessment: Lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr. 2004;79:613–618. doi: 10.1093/ajcn/79.4.613. [DOI] [PubMed] [Google Scholar]
  • 11.van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–557. doi: 10.1002/bjs.7823. [DOI] [PubMed] [Google Scholar]
  • 12.Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 2008;9:629–635. doi: 10.1016/S1470-2045(08)70153-0. [DOI] [PubMed] [Google Scholar]
  • 13.Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261:1173–1183. doi: 10.1097/SLA.0000000000000743. [DOI] [PubMed] [Google Scholar]
  • 14.Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, Edil BH, Wolfgang CL, Schulick RD, Choti MA, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011;13:439–446. doi: 10.1111/j.1477-2574.2011.00301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Valero V, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, Wolfgang CL, Cameron AA, Philosophe B, Kamel IR, Pawlik TM. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg. 2015;19:272–281. doi: 10.1007/s11605-014-2680-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015;39:1494–1500. doi: 10.1007/s00268-015-2988-6. [DOI] [PubMed] [Google Scholar]
  • 17.Kazama K, Aoyama T, Hayashi T, Yamada T, Numata M, Amano S, Kamiya M, Sato T, Yoshikawa T, Shiozawa M, et al. Evaluation of short-term outcomes of laparoscopic-assisted surgery for colorectal cancer in elderly patients aged over 75 years old: A multi-institutional study (YSURG1401) BMC Surg. 2017;17:29. doi: 10.1186/s12893-017-0229-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sobin LH, Gospodarowicz MK, Wittekind Ch. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 7th edition. Wiley-Blackwell; Chichester: 2010. [Google Scholar]
  • 19.Japanese Society for Cancer of the Colon and Rectum: Guidelines for Therapy of Colorectal Cancer. Kanehara Shuppan; Tokyo: 2010. [Google Scholar]
  • 20.Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 8th edition. Kanehira-Syuppan; Tokyo: 2013. (In Japanese) [Google Scholar]
  • 21.Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of survey. Ann surg. 2004;240:205–213. doi: 10.1097/01.sla.0000133083.54934.ae. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Margadant CC, Bruns ER, Sloothaak DA, van Duijvendijk P, van Raamt AF, van der Zaag HJ, Buskens CJ, van Munster BC, van der Zaag ES. Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer. Eur J Surg Oncol. 2016;42:1654–1659. doi: 10.1016/j.ejso.2016.05.040. [DOI] [PubMed] [Google Scholar]
  • 23.Boer BC, de Graaff F, Brusse-Keizer M, Bouman DE, Slump CH, Slee-Valentijn M, Klaase JM. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis. 2016;31:1117–1124. doi: 10.1007/s00384-016-2538-1. [DOI] [PubMed] [Google Scholar]
  • 24.Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–936. doi: 10.1038/bjc.2012.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, Kennedy RH, Fearon KC, Jenkins JT. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103:572–580. doi: 10.1002/bjs.10075. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Molecular and Clinical Oncology are provided here courtesy of Spandidos Publications

RESOURCES